麻省理工学院Broad研究所、哈佛大学和赛勒斯生物技术公司的研究人员现在已经设计了两种CRISPR核酸酶，Cas9和Cas12，以掩盖它们对免疫系统的影响。该团队确定了每个核酸酶上触发免疫系统的蛋白质序列，并使用计算建模来设计逃避免疫识别的新版本。与小鼠的标准核酸酶相比，工程酶具有相似的基因编辑效率和降低的免疫反应。

The core components of CRISPR-based genome-editing therapies are bacterial proteins called nucleases that can stimulate ...

Imagine a world where the genetic code is as easy to edit as a simple copy-and-paste. This is the reality of CRISPR, a ...

CRISPR-Cas9 pioneer presented with National Medal of Technology and Innovation in White House awards ceremony.

Looking at the volume and open interest is an insightful way to conduct due diligence on a stock. This data can help you ...

Then Crispr came along—the elegant enzymatic apparatus that allows delivery of DNA scissors to a specific target in the genome. In December 2023, the FDA approved the first Crispr-based therapy ...

ZUG, Switzerland and BOSTON, Jan. 08, 2025 (GLOBE NEWSWIRE) -- CRISPR Therapeutics (Nasdaq: CRSP), a biopharmaceutical company focused on creating transformative gene-based medicines for serious ...

After hours: January 10 at 7:58:14 PM EST Loading Chart for CRSP ...

瑞士楚格和美国波士顿 - 基因医学开发领域的领导者CRISPR Therapeutics (NASDAQ:CRSP)今天宣布，计划在即将举行的年度股东大会上任命Briggs Morrison医学博士为董事会成员。Morrison在临床开发和制药行业的丰富经验预计将支持公司推进基因编辑疗法的发展。根据 InvestingPro ...

Researchers at the Experimental and Clinical Research Center in Berlin are developing a targeted treatment for muscular ...

Scribe Therapeutics has laid off just under 20% of its staff, the company confirmed to STAT on Wednesday, joining a slate of CRISPR gene editing companies to cut staff amid a prolonged downturn ...